NanoViricides
NNVC
#10648
Rank
NZ$51.64 M
Marketcap
NZ$2.02
Share price
10.95%
Change (1 day)
-16.43%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): NZ-$0.77

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$0.76. In 2025 the company made an earnings per share (EPS) of NZ-$1.09 an increase over its 2024 EPS that were of NZ-$1.22.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.77-30.01%
2025NZ-$1.09-10%
2024NZ-$1.22-5.41%
2023NZ-$1.295.71%
2022NZ-$1.22-13.58%
2021NZ-$1.41-66.11%
2020NZ-$4.151.7%
2019NZ-$4.08-10.98%
2018NZ-$4.58-22.35%
2017NZ-$5.90-10.53%
2016NZ-$6.60375%
2015NZ-$1.39-85.19%
2014NZ-$9.3842.11%
2013NZ-$6.6026.67%
2012NZ-$5.21-6.25%
2011NZ-$5.5614.28%
2010NZ-$4.86100%
2009NZ-$2.43-0%
2008NZ-$2.43-33.33%
2007NZ-$3.65-0%
2006NZ-$3.654445.07%
2005NZ-$0.08024

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$12.89-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.21-912.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.18-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.75-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$0.94 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$3.00 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA